Accéder au contenu
Merck
Toutes les photos(2)

Key Documents

View All Documentation

11873601001

Roche

Pefabloc® SC PLUS

crystalline, suitable for blocking, suitable for protein purification, 0.1-1.0 mg/mL

Synonyme(s) :

pefabloc, serine protease inhibitor

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Code UNSPSC :
12352204

Forme

crystalline

Niveau de qualité

100

Poids mol.

239.5

Conditionnement

pkg of 5 mL (100 mg)

Fabricant/nom de marque

Roche

Concentration

0.1-1.0 mg/mL

Technique(s)

blocking: suitable
protein purification: suitable

pH optimal

neutral

Pf

175-185 °C

Solubilité

soluble (Solubility and stability of the protease inhibitor remains unchanged.)

Température de stockage

2-8°C

Description générale

Pefabloc SC is a specific, potent, and irreversible inhibitor of serine proteases. The inhibitory activity is comparable to PMSF or DFP, but Pefabloc SC is nontoxic to cells. The Pefabloc SC PLUS set combines the serine protease inhibitor Pefabloc SC with a uniquely formulated Pefabloc SC protector (PSC-Protector), adding additional convenience and reliability to the safe, stable protease inhibition provided by Pefabloc SC.

Recent findings indicate that sulfonyl-type serine protease inhibitors such as Pefabloc SC and PMSF can bind covalently to proteins. This can occur when the inhibitors are used in high concentrations, or during extended incubation times under alkaline conditions. This interaction adversely affects the tyrosine and lysine residues of a protein, as well as the free amino terminus. The PLUS additive (PSC-Protector) included with this set prevents covalent attachment of Pefabloc SC to proteins when used in higher concentrations and extended incubation times at an alkaline pH.

Spécificité

Pefabloc SC belongs to the family of sulfonyl fluorides which irreversibly block serine proteases. Pefabloc was also described as potent serine threonine phosphatase inhibitor.
Specific, potent, and irreversible inhibitor of serine proteases. The inhibitory activity of Pefabloc SC is comparable to PMSF or DFP; however, Pefabloc SC is non-toxic. Specifically inhibits serine proteases and prevents nonspecific covalent modification of proteins as tested by mass spectrometry.

Application

  • Pefabloc® SC is used to inhibit the detrimental effects of proteases during preparative protein purification. The PSC-protector solution prevents nonspecific covalent modification of proteins when Pefabloc is used in higher concentrations and extended incubation times at an alkaline pH (tested by mass spectrometry).
  • Due to its low toxicity toward eukaryotic cells, it may be applied in the production of recombinant proteins, during fermentation of transformed cells, where proteolytic digestion may decrease the yield of the desired product.
  • Pefabloc SC is used to completely inactivate proteinase K during the preparation of chromosomal DNA in agarose plugs. For this purpose, the cells are embedded in agarose and digested with proteinase K to degrade all proteins. Before a specific restriction endonuclease is added, the proteinase K is inactivated by incubating the agarose plugs in 1 – 5 mM Pefabloc SC in 10 mM Tris-HCl, 1 mM EDTA , pH 7 for 2 hours at +37 °C or overnight.
  • In contrast to PMSF, Pefabloc SC is an excellent blocker of thrombin activity in serum or plasma. In these biological fluids, PMSF interacts in a reversible manner with albumin, which reduces its free concentration and leads to a delay in thrombin inactivation. Pefabloc SC, however, does not react with serum albumin, and exhibits a threefold higher capacity to inactivate thrombin under similar conditions.
  • Pefabloc SC can be used on living cells.
Pefabloc® SC PLUS has been used in digitonin extraction buffer and in cathepsin B activity assay buffer in THP-1 cells. It has also been used as a component of iodixanol solution and sucrose buffer for the isolation of nuclei from Xenopus embryos.

Caractéristiques et avantages

  • Take advantage of a simplified two-reagent system. Use the PSC-Protector solution to prevent covalent binding between proteins and Pefabloc SC, even at high concentrations, extended incubation times, and at alkaline pH.
  • Benefit from an easy-to-use inhibitor. Add water-soluble Pefabloc SC directly to aqueous buffers.
  • Avoid hazardous compounds. Obtain non-toxic protease inhibition without risk to you, or those around you.
  • Ensure protection with improved stability. Achieve consistent protease inhibition even at pH levels above 7.0 and temperatures above +4°C.
  • Maximize inhibition. Be certain that your levels of active inhibitor are high enough by using a product that is reliably soluble and stable.

Conditionnement

Set containing two components

Notes préparatoires

Working concentration: 0.1 - 1.0 mg/ml (0.4 - 4 mM)
Pefabloc SC plus the corresponding amount of PSC-protector
Working solution: Recommended solvent is distilled water or aqueous buffer (for Pefabloc SC).
The solubility is up to 0.1 M for Pefabloc SC.
Storage conditions (working solution): -15 to -25 °C (stock solution)
Solubility and stability of the protease inhibitor remains unchanged. See Pefabloc SC.

Reconstitution

Solubility and stability of the protease inhibitor remains unchanged. See Pefabloc SC.

Autres remarques

For life science research only. Not for use in diagnostic procedures.

Informations légales

Pefabloc is a registered trademark of Pentapharm

Composants de kit seuls

Réf. du produit
Description
  • Pefabloc SC, 100 mg
  • PSC-Protector solution, 5 mL ready-to-use

Pictogrammes

FlameCorrosion
GHS02,GHS05

Mention d'avertissement

Danger

Mentions de danger

H226,H314

Classification des risques

Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1B

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 1

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

DNase-seq to study chromatin accessibility in early Xenopus tropicalis embryos
Cho JS, et al.
Cold Spring Harbor Protocols, 4 (2019)
Yonggang Zhang et al.
Oncotarget, 6(8), 6160-6178 (2015-02-24)
Regulatory mechanisms underlying constitutive and inducible NFκB activation in cancer remain largely unknown. Here we investigated whether a novel NIK- and IKK2-binding protein (NIBP) is required for maintaining malignancy of cancer cells in an NFκB-dependent manner. Real-time polymerase chain reaction
Chikodili C Nduaguibe et al.
Islets, 2(3), 200-206 (2010-11-26)
Pefabloc, Trasylol and Urinary Trypsin Inhibitor (UTI) have been reported to be effective serine protease inhibitors that impair pancreatic endogenous proteases resulting in improved islet yield. Here we evaluated the effect of these inhibitors on endogenous proteases (trypsin, chymotrypsin and
Nicolai J Wewer Albrechtsen et al.
Endocrine connections, 4(1), 50-57 (2015-01-18)
To investigate the stability of glucagon-like peptide 1 (GLP-1) and glucagon in plasma under short- and long-term storage conditions. Pooled human plasma (n=20), to which a dipeptidyl peptidase 4 (DPP4) inhibitor and aprotinin were added, was spiked with synthetic GLP-1
Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition
Tran UT and Kitami T
Communications biology, 2(1), 2-2 (2019)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique